taxifolin has been researched along with Alcoholic Fatty Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, M; Jiao, JY; Lian, LH; Lin, YC; Liu, J; Nan, JX; Piao, MH; Qiao, CY; Shang, Y; Sun, RH; Wu, M; Wu, YL; Ye, H; Zhan, ZY; Zhang, ZH | 1 |
| Cui, BW; Jiang, M; Jin, Q; Li, X; Lian, LH; Nan, JX; Wu, YL; Xia, KL; Zhang, Y | 1 |
2 other study(ies) available for taxifolin and Alcoholic Fatty Liver
| Article | Year |
|---|---|
Taxifolin ameliorate high-fat-diet feeding plus acute ethanol binge-induced steatohepatitis through inhibiting inflammatory caspase-1-dependent pyroptosis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Binge Drinking; Cells, Cultured; Central Nervous System Depressants; Diet, High-Fat; Disease Models, Animal; Ethanol; Fatty Liver, Alcoholic; Humans; Male; Mice; Mice, Inbred ICR; Pyroptosis; Quercetin | 2021 |
Amelioration of Alcoholic Liver Steatosis by Dihydroquercetin through the Modulation of AMPK-Dependent Lipogenesis Mediated by P2X7R-NLRP3-Inflammasome Activation.
Topics: AMP-Activated Protein Kinases; Animals; Fatty Liver, Alcoholic; Humans; Inflammasomes; Lipogenesis; Liver; Male; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Quercetin; Receptors, Purinergic P2X7 | 2018 |